Frequency of community-acquired pneumonia in children aged 5 to 12 years in the Provincial Health Center N°48 of the city of Rosario
DOI:
https://doi.org/10.62486/agmu202420Keywords:
Community Pneumonia, Pediatric Patients, Risk Factors, Symptoms, TreatmentAbstract
Community-acquired pneumonia (CAP) is a relevant cause of morbidity in children under 10 years of age. This study at the Provincial Health Center N°48 in Rosario, Argentina, analyzed the frequency of CAP in children aged 5 to 12 years during 2023, using medical records of 30 patients. Fifty-three percent were girls and 47% boys, with an average age of 8.37 years. The main risk factors were asthma, bronchial hyperresponsiveness and recurrent respiratory infections (40%), malnutrition (33%) and preterm birth (20%). Common symptoms included fever, productive cough and chills. Ninety percent of the cases were treated with oral Amoxicillin. It is concluded that the frequency of CAP was low (4%) and that Amoxicillin was effective as an initial treatment.
References
de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet Lond Engl 2020;396:786-98. https://doi.org/10.1016/S0140-6736(20)31550-6. DOI: https://doi.org/10.1016/S0140-6736(20)31550-6
Moreno-Pérez D, Andrés A, Tagarro A, Escribano A, Figuerola J, García JJ, et al. Neumonía adquirida en la comunidad: tratamiento ambulatorio y prevención. An Pediatr 2015;83:439 1-439 7. https://doi.org/10.1016/j.anpedi.2014.10.028. DOI: https://doi.org/10.1016/j.anpedi.2014.10.028
Giménez Sánchez F, Sánchez Marenco A, Battles Garrido JMa, López Soler JA, Sánchez-Solís Querol M. Características clínico-epidemiológicas de la neumonía adquirida en la comunidad en niños menores de 6 años. An Pediatría 2007;66:578-84. https://doi.org/10.1157/13107392. DOI: https://doi.org/10.1157/13107392
Visbal Spirko LP, Galindo López J, Orozco Cepeda K, Vargas Rumilla MI. Neumonía adquirida en la comunidad en pediatría. Rev Científica Salud Uninorte 2007;23.
Bernztein R, Drake I. Neumonía de la comunidad en niños: impacto sanitario y costos del tratamiento en el primer nivel de atención público de la Argentina. Arch Argent Pediatr 2009;107:101-10. https://doi.org/10.5546/aap.2012.101. DOI: https://doi.org/10.5546/aap.2012.101
Ahn JG, Cho H-K, Li D, Choi M, Lee J, Eun B-W, et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis 2021;21:1003. https://doi.org/10.1186/s12879-021-06508-7. DOI: https://doi.org/10.1186/s12879-021-06508-7
Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 2021;93:1057-69. https://doi.org/10.1002/jmv.26398. DOI: https://doi.org/10.1002/jmv.26398
Martín A, Moreno-Pérez D, Alfayate S, Couceiro JA, García ML, Korta J, et al. Etiología y diagnóstico de la neumonía adquirida en la comunidad y sus formas complicadas. An Pediatr 2012;76:162 1-162 18. https://doi.org/10.1016/j.anpedi.2011.09.011. DOI: https://doi.org/10.1016/j.anpedi.2011.09.011
Martínez Santander CJ, Flores Paredes SA, Pesantez Ferreira AD, Suquinagua Ortiz MD, Bravo Vázquez CA, Guevara Carvajal MC. Prevalencia de la neumonía en pacientes pediátricos en Latinoamérica durante el periodo 2017-2022. Mediciencias UTA 2022;6:108-22. https://doi.org/10.31243/mdc.uta.v6i4.1819.2022. DOI: https://doi.org/10.31243/mdc.uta.v6i4.1819.2022
González J, Julián-Jiménez A, Candel FJ, Urgencias. IdISSC. Hospital Clínico San Carlos. Madrid S, Spain. Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications. Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter 2021;34:599-609. https://doi.org/10.37201/req/144.2021. DOI: https://doi.org/10.37201/req/144.2021
Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG, et al. Pneumonia. Nat Rev Dis Primer 2021;7:25. https://doi.org/10.1038/s41572-021-00259-0. DOI: https://doi.org/10.1038/s41572-021-00259-0
Redondo E, Rivero I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, et al. Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del Grupo de Neumoexpertos en Prevención. SEMERGEN - Med Fam 2016;42:464-75. https://doi.org/10.1016/j.semerg.2016.07.009. DOI: https://doi.org/10.1016/j.semerg.2016.07.009
Ensinck G, Lazarte G, Ernst A, Romagnoli A, López Papucci S, Aletti A, et al. Neumonía por Staphylococcus aureus resistente a meticilina adquirido de la comunidad en un hospital pediátrico. Nuestra experiencia de 10 años. Arch Argent Pediatr 2021;119:11-7. DOI: https://doi.org/10.5546/aap.2021.11
World Medical Association. Declaración de Helsinki: Principios éticos para las investigaciones médicas en participantes humanos. World Med Assoc 2024. https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/ (accedido 31 de octubre de 2024).
Senado y Cámara de Diputados de la Nación Argentina. Ley de Protección de los Datos Personales. 2000.
Sociedad Peruana de Enfermedades Infecciosas y Tropicales. Guía de práctica clínica: neumonía adquirida en la comunidad en niños. 1ra ed. Lima, Perú: OPS; 2009.
Davis Rocha C, Padilla R. Factores de riesgo socioculturales asociado a Neumonía Adquirida en la Comunidad desde la cosmovisión indígena Miskitu en niños menores de 5 años. Tesis de grado. Universidad de las Regiones Autónomas de la Costa Caribe Nicaragüense, 2020.
Kasundriya SK, Dhaneria M, Mathur A, Pathak A. Incidence and Risk Factors for Severe Pneumonia in Children Hospitalized with Pneumonia in Ujjain, India. Int J Environ Res Public Health 2020;17:4637. https://doi.org/10.3390/ijerph17134637. DOI: https://doi.org/10.3390/ijerph17134637
Alberto Magaña SP. Perfil clínico y epidemiológico de pacientes de 3 meses a 12 años con diagnóstico de neumonía adquirida en la comunidad refereridos por necesidad de soporte ventilatorio al Hospital Nacional de Niños Benjamín Bloom, entre 1 de Enero 2012 y 31 de Deciembre 2017. Tesis de postgrado. Universidad de El Salvador, 2020.
Jullien S, Pradhan D, Tshering T, Sharma R, Dema K, Garcia-Garcia S, et al. Pneumonia in children admitted to the national referral hospital in Bhutan: A prospective cohort study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2020;95:74-83. https://doi.org/10.1016/j.ijid.2020.04.017. DOI: https://doi.org/10.1016/j.ijid.2020.04.017
Chang TH, Liu YC, Lin SR, Chiu PH, Chou CC, Chang LY, et al. Clinical characteristics of hospitalized children with community-acquired pneumonia and respiratory infections: Using machine learning approaches to support pathogen prediction at admission. J Microbiol Immunol Infect 2023;56:772-81. https://doi.org/10.1016/j.jmii.2023.04.011. DOI: https://doi.org/10.1016/j.jmii.2023.04.011
Tsai T-A, Tsai C-K, Kuo K-C, Yu H-R. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi 2021;54:557-65. https://doi.org/10.1016/j.jmii.2020.10.002. DOI: https://doi.org/10.1016/j.jmii.2020.10.002
Chee E, Huang K, Haggie S, Britton PN. Systematic review of clinical practice guidelines on the management of community acquired pneumonia in children. Paediatr Respir Rev 2022;42:59-68. https://doi.org/10.1016/j.prrv.2022.01.006. DOI: https://doi.org/10.1016/j.prrv.2022.01.006
Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community- acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004;9:109-14. https://doi.org/10.1111/j.1440-1843.2003.00522.x. DOI: https://doi.org/10.1111/j.1440-1843.2003.00522.x
Chapman TJ, Olarte L, Dbaibo G, Houston AM, Tamms G, Lupinacci R, et al. PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children. Expert Rev Vaccines 2024;23:137-47. https://doi.org/10.1080/14760584.2023.2294153. DOI: https://doi.org/10.1080/14760584.2023.2294153
Published
Issue
Section
License
Copyright (c) 2024 Julieta Ivana Passas (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
